• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

阿片受体和阿片类药物的质子偶联结合。

Opioid Receptors and Protonation-Coupled Binding of Opioid Drugs.

机构信息

Faculty of Chemistry and Chemical Engineering, University of Maribor, SI-2000 Maribor, Slovenia.

Theoretical Molecular Biophysics Group, Department of Physics, Freie Universität Berlin, 14195 Berlin, Germany.

出版信息

Int J Mol Sci. 2021 Dec 12;22(24):13353. doi: 10.3390/ijms222413353.

DOI:10.3390/ijms222413353
PMID:34948150
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8707250/
Abstract

Opioid receptors are G-protein-coupled receptors (GPCRs) part of cell signaling paths of direct interest to treat pain. Pain may associate with inflamed tissue characterized by acidic pH. The potentially low pH at tissue targeted by opioid drugs in pain management could impact drug binding to the opioid receptor, because opioid drugs typically have a protonated amino group that contributes to receptor binding, and the functioning of GPCRs may involve protonation change. In this review, we discuss the relationship between structure, function, and dynamics of opioid receptors from the perspective of the usefulness of computational studies to evaluate protonation-coupled opioid-receptor interactions.

摘要

阿片受体是 G 蛋白偶联受体 (GPCR),是直接参与治疗疼痛的细胞信号通路的一部分。疼痛可能与炎症组织有关,炎症组织的特点是 pH 值较低。在疼痛管理中,阿片类药物靶向的组织中潜在的低 pH 值可能会影响药物与阿片受体的结合,因为阿片类药物通常具有一个质子化的氨基,有助于与受体结合,而 GPCR 的功能可能涉及质子化的变化。在这篇综述中,我们从计算研究评估质子偶联阿片受体相互作用的有用性的角度讨论了阿片受体的结构、功能和动力学之间的关系。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d940/8707250/339340e13875/ijms-22-13353-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d940/8707250/4198d3848939/ijms-22-13353-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d940/8707250/81b482bda5e9/ijms-22-13353-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d940/8707250/80d05d2af368/ijms-22-13353-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d940/8707250/f6d99fe9c8ee/ijms-22-13353-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d940/8707250/dad717c3c1da/ijms-22-13353-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d940/8707250/01761b865f73/ijms-22-13353-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d940/8707250/f62bbc71d948/ijms-22-13353-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d940/8707250/339340e13875/ijms-22-13353-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d940/8707250/4198d3848939/ijms-22-13353-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d940/8707250/81b482bda5e9/ijms-22-13353-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d940/8707250/80d05d2af368/ijms-22-13353-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d940/8707250/f6d99fe9c8ee/ijms-22-13353-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d940/8707250/dad717c3c1da/ijms-22-13353-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d940/8707250/01761b865f73/ijms-22-13353-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d940/8707250/f62bbc71d948/ijms-22-13353-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d940/8707250/339340e13875/ijms-22-13353-g008.jpg

相似文献

1
Opioid Receptors and Protonation-Coupled Binding of Opioid Drugs.阿片受体和阿片类药物的质子偶联结合。
Int J Mol Sci. 2021 Dec 12;22(24):13353. doi: 10.3390/ijms222413353.
2
Potential Energy Function for Fentanyl-Based Opioid Pain Killers.芬太尼类阿片类止痛药的势能函数。
J Chem Inf Model. 2020 Jul 27;60(7):3566-3576. doi: 10.1021/acs.jcim.0c00185. Epub 2020 Jun 19.
3
Fentanyl and the Fluorinated Fentanyl Derivative NFEPP Elicit Distinct Hydrogen-Bond Dynamics of the Opioid Receptor.芬太尼和氟代芬太尼衍生物 NFEPP 诱发阿片受体的独特氢键动力学。
J Chem Inf Model. 2023 Aug 14;63(15):4732-4748. doi: 10.1021/acs.jcim.3c00197. Epub 2023 Jul 27.
4
Recent developments in the study of opioid receptors.阿片受体研究的最新进展。
Mol Pharmacol. 2013 Apr;83(4):723-8. doi: 10.1124/mol.112.083279. Epub 2012 Dec 18.
5
[Endomorphins in pain relief. New endogenous peptides a sensational discovery].[内吗啡肽与疼痛缓解。新型内源性肽类——一项轰动性发现]
Lakartidningen. 1997 Sep 3;94(36):3019-21.
6
Tuning Down the Pain - An Overview of Allosteric Modulation of Opioid Receptors: Mechanisms of Modulation, Allosteric Sites, Modulator Syntheses.下调疼痛——阿片受体变构调节概述:调节机制、变构结合部位、调节剂合成。
Curr Top Med Chem. 2020;20(31):2852-2865. doi: 10.2174/1568026620666200601155451.
7
Novel Opioid Analgesics and Side Effects.新型阿片类镇痛药及副作用。
ACS Chem Neurosci. 2017 Aug 16;8(8):1638-1640. doi: 10.1021/acschemneuro.7b00195. Epub 2017 Jun 12.
8
Allosteric Modulation of Opioid G-Protein Coupled Receptors by Sigma Receptors.西格玛受体对阿片类G蛋白偶联受体的变构调节
Handb Exp Pharmacol. 2017;244:163-175. doi: 10.1007/164_2017_34.
9
Multiple ligands in opioid research.阿片类药物研究中的多种配体。
Protein Pept Lett. 2008;15(7):668-82. doi: 10.2174/092986608785133672.
10
Grand opening of structure-guided design for novel opioids.新型阿片类药物结构导向设计的盛大开业。
Trends Pharmacol Sci. 2013 Jan;34(1):6-12. doi: 10.1016/j.tips.2012.10.002. Epub 2012 Nov 3.

引用本文的文献

1
Effects of pH on opioid receptor activation and implications for drug design.pH对阿片受体激活的影响及其在药物设计中的意义。
Biophys J. 2024 Dec 17;123(24):4158-4166. doi: 10.1016/j.bpj.2024.07.007. Epub 2024 Jul 5.
2
Novel roles of -opioid receptor in myocardial ischemia-reperfusion injury.-阿片受体在心肌缺血再灌注损伤中的新作用。
PeerJ. 2024 Jun 25;12:e17333. doi: 10.7717/peerj.17333. eCollection 2024.
3
Involvement of the Opioid Peptide Family in Cancer Progression.阿片肽家族在癌症进展中的作用

本文引用的文献

1
C-Graphs Tool with Graphical User Interface to Dissect Conserved Hydrogen-Bond Networks: Applications to Visual Rhodopsins.C-Graphs 工具具有图形用户界面,可用于剖析保守的氢键网络:在视觉视紫红质中的应用。
J Chem Inf Model. 2021 Nov 22;61(11):5692-5707. doi: 10.1021/acs.jcim.1c00827. Epub 2021 Oct 20.
2
CHARMM Force-Field Parameters for Morphine, Heroin, and Oliceridine, and Conformational Dynamics of Opioid Drugs.吗啡、海洛因和奥里替定的CHARMM力场参数以及阿片类药物的构象动力学
J Chem Inf Model. 2021 Aug 23;61(8):3964-3977. doi: 10.1021/acs.jcim.1c00667. Epub 2021 Aug 5.
3
Delineating the Ligand-Receptor Interactions That Lead to Biased Signaling at the μ-Opioid Receptor.
Biomedicines. 2023 Jul 14;11(7):1993. doi: 10.3390/biomedicines11071993.
4
Computational design and molecular modeling of morphine derivatives for preferential binding in inflamed tissue.吗啡衍生物在炎症组织中优先结合的计算设计和分子建模。
Pharmacol Res Perspect. 2023 Jun;11(3):e01075. doi: 10.1002/prp2.1075.
5
Modelling altered signalling of G-protein coupled receptors in inflamed environment to advance drug design.在炎症环境中模拟改变的 G 蛋白偶联受体信号转导以推进药物设计。
Sci Rep. 2023 Jan 12;13(1):607. doi: 10.1038/s41598-023-27699-w.
6
A comprehensive evaluation of the potential binding poses of fentanyl and its analogs at the µ-opioid receptor.对芬太尼及其类似物在μ-阿片受体上潜在结合构象的全面评估。
Comput Struct Biotechnol J. 2022 May 14;20:2309-2321. doi: 10.1016/j.csbj.2022.05.013. eCollection 2022.
描绘导致μ-阿片受体偏向性信号传导的配体-受体相互作用
J Chem Inf Model. 2021 Jul 26;61(7):3696-3707. doi: 10.1021/acs.jcim.1c00585. Epub 2021 Jul 12.
4
Positive allosteric modulation of the mu-opioid receptor produces analgesia with reduced side effects.μ-阿片受体的正变构调节可产生镇痛作用,且副作用减少。
Proc Natl Acad Sci U S A. 2021 Apr 20;118(16). doi: 10.1073/pnas.2000017118.
5
Agonist that activates the µ-opioid receptor in acidified microenvironments inhibits colitis pain without side effects.在酸化的微环境中激活 μ 阿片受体的激动剂可抑制结肠炎疼痛而无副作用。
Gut. 2022 Apr;71(4):695-704. doi: 10.1136/gutjnl-2021-324070. Epub 2021 Mar 30.
6
How μ-opioid receptor recognizes fentanyl.μ-阿片受体如何识别芬太尼。
Nat Commun. 2021 Feb 12;12(1):984. doi: 10.1038/s41467-021-21262-9.
7
Structural Assessment of Agonist Efficacy in the μ-Opioid Receptor: Morphine and Fentanyl Elicit Different Activation Patterns.μ-阿片受体激动剂效力的结构评估:吗啡和芬太尼引发不同的激活模式。
J Chem Inf Model. 2021 Mar 22;61(3):1251-1274. doi: 10.1021/acs.jcim.0c00890. Epub 2021 Jan 15.
8
The Life Cycle of the Mu-Opioid Receptor.μ-阿片受体的生命周期
Trends Biochem Sci. 2021 Apr;46(4):315-328. doi: 10.1016/j.tibs.2020.10.002. Epub 2020 Oct 27.
9
A low pKa ligand inhibits cancer-associated pain in mice by activating peripheral mu-opioid receptors.低 pKa 配体通过激活外周 μ 阿片受体抑制小鼠癌相关性疼痛。
Sci Rep. 2020 Oct 29;10(1):18599. doi: 10.1038/s41598-020-75509-4.
10
Affinity, potency, efficacy, selectivity, and molecular modeling of substituted fentanyls at opioid receptors.取代芬太尼对阿片受体的亲和力、效价、效能、选择性及分子模拟
Biochem Pharmacol. 2020 Dec;182:114293. doi: 10.1016/j.bcp.2020.114293. Epub 2020 Oct 20.